Floatz logo

Anti-Cd7 Car-Pnk Cells

Enteropathy-type Intestinal T-cell Lymphoma

PersonGen BioTherapeutics (Suzhou) Co., Ltd.Cell therapyPhase 1/2Dormant
CCC
48/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
33/ 100
Competitive Position
95/ 100

Competitive context

21 Active assets in the Enteropathy-type Intestinal T-cell Lymphoma cohort.

Asset / SponsorPhaseRating
ETOPOSIDE
Eric Jacobsen, MD
Phase 4BBB
Inno-206
Eric Jacobsen, MD
Phase 4BBB
Cyclophosphamide
National Cancer Institute (NCI)
Phase 4BBB
Ifosfamide
Shandong Provincial Hospital
Phase 4BB
PREDNISONE TABLETS
Eric Jacobsen, MD
Phase 4BB

View all 36 →

Same molecule, other indications

Anti-Cd7 Car-Pnk Cells is also rated in:

T-cell large granular lymphocyte leukemiaDormant
CCC
Indicative ·
48 / 100
View asset →
peripheral T-cell lymphoma, not otherwise specifiedDormant
CCC
Indicative ·
48 / 100
View asset →
extranodal nasal NK/T cell lymphomaDormant
CCC
Indicative ·
48 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →